From the Guidelines
Hospital admission is necessary for ulcerative colitis (UC) flares with systemic symptoms, such as fever, severe pain, significant anemia, or those who are generally unwell and not tolerating their symptoms, as outlined in the British Society of Gastroenterology consensus guidelines 1. When determining the need for hospital versus outpatient treatment of a UC flare, the following factors should be considered:
- Severity of symptoms: Patients with mild to moderate symptoms, such as increased stool frequency (4-6 per day), mild abdominal pain, and minimal systemic symptoms, can be managed as outpatients 1.
- Systemic symptoms: Presence of systemic symptoms, such as fever, severe pain, significant anemia, or being generally unwell, necessitates hospital admission 1.
- Response to treatment: Patients not responding to oral corticosteroids after 2 weeks should be considered for treatment escalation to biologics or admission to hospital, depending on the severity of their symptoms 1. Key considerations for outpatient treatment include:
- Oral mesalamine (up to 4.8g daily)
- Oral prednisone (40-60mg daily, tapering over 8-12 weeks)
- Topical therapy (mesalamine enemas or suppositories) In contrast, hospital admission is required for severe flares, with management including:
- IV corticosteroids (methylprednisolone 60mg daily or hydrocortisone 100mg every 8 hours)
- IV fluids and electrolyte replacement
- Consideration of rescue therapy (infliximab or cyclosporine) if no improvement within 3-5 days
- Surgical consultation for potential colectomy if medical management fails Additional considerations for hospitalized patients include:
- Assessing for infections (C. difficile, CMV)
- Monitoring electrolytes, CBC, and CRP daily
- Initiating DVT prophylaxis
- Ensuring adequate nutrition, with consideration of total parenteral nutrition (TPN) if severe disease 1.
From the Research
Clinical Criteria for Determining Hospital vs Outpatient Treatment of UC Flare
The decision to treat an ulcerative colitis (UC) flare in a hospital or outpatient setting depends on several clinical criteria.
- Disease severity: Patients with mild-to-moderate UC can often be managed in an outpatient setting with medications such as aminosalicylates, corticosteroids, or biologic agents 2, 3, 4.
- Extent of inflammation: The endoscopic extent of inflammation is an important factor in determining the treatment approach 5.
- Patient symptoms: Patients with severe symptoms, such as significant bleeding, abdominal pain, or high fever, may require hospitalization 5.
- Response to initial treatment: Patients who do not respond to initial outpatient treatment may require hospitalization for further management 6.
- Presence of complications: Patients with complications such as Clostridium difficile or cytomegalovirus colitis may require hospitalization for treatment 6.
Treatment Approaches
Treatment approaches for UC flares vary depending on the severity of the disease and the patient's response to initial treatment.
- Mild-to-moderate UC: Aminosalicylates, such as mesalamine, are often used as first-line treatment for mild-to-moderate UC 3, 4.
- Moderate-to-severe UC: Corticosteroids, such as budesonide, or biologic agents, such as infliximab or vedolizumab, may be used to treat moderate-to-severe UC 4, 5.
- Severe UC: Hospitalization may be required for patients with severe UC, and treatment may include intravenous corticosteroids or biologic agents 5.